Clinical trial
Prediction of ST2 for impRovement of Left ventricUlar Systolic funcTion After Percutaneous Coronary Intervention in Patients With acutE Coronary synDrome
NCT03841214 is registered in ClinicalTrials.gov with Keimyung University Dongsan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction of ST2 for impRovement of Left ventricUlar Systolic funcTion After Percutaneous Coronary Intervention in Patients With acutE Coronary synDrome
- Lead sponsor
- Keimyung University Dongsan Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 25, 2019
- Completion date
- June 30, 2021
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.